|
NARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.418100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.824900E-03 |
| Normal-vs-Stage2 |
4.044800E-01 |
| Normal-vs-Stage3 |
3.300600E-03 |
| Normal-vs-Stage4 |
1.151870E-04 |
| Stage1-vs-Stage2 |
6.877400E-01 |
| Stage1-vs-Stage3 |
1.290040E-01 |
| Stage1-vs-Stage4 |
1.581170E-01 |
| Stage2-vs-Stage3 |
2.005000E-01 |
| Stage2-vs-Stage4 |
1.073630E-01 |
| Stage3-vs-Stage4 |
7.077400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.183700E-02 |
| Normal-vs-AfricanAmerican |
1.005910E-04 |
| Normal-vs-Asian |
2.948000E-01 |
| Caucasian-vs-AfricanAmerican |
2.282400E-02 |
| Caucasian-vs-Asian |
3.742600E-01 |
| AfricanAmerican-vs-Asian |
9.018600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.481100E-03 |
| Normal-vs-Female |
1.123200E-01 |
| Male-vs-Female |
3.813400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.442600E-04 |
| Normal-vs-Extreme_Weight |
3.301700E-03 |
| Normal-vs-Obese |
1.326820E-01 |
| Normal-vs-Extreme_Obese |
1.921020E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.783200E-01 |
| Normal_Weight-vs-Obese |
1.408240E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.052800E-01 |
| Extreme_Weight-vs-Obese |
3.618000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.802200E-01 |
| Obese-vs-Extreme_Obese |
5.787000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.093600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.414400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.120000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.954780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.192000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.218600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.125200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.380200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.733600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.599600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.181220E-01 |
| Normal-VS-Type2 PRCC |
1.57154999999021E-05 |
| Normal-VS-KIRP CIMP |
4.381600E-01 |
| Normal-VS-Unclassified PRCC |
5.005800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.638900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.223200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.413400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.516800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.662180E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.376800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.777900E-03 |
| Normal-vs-N1 |
9.982400E-02 |
| Normal-vs-N2 |
2.30619999999071E-05 |
| N0-vs-N1 |
9.770800E-01 |
| N0-vs-N2 |
1.440750E-01 |
| N1-vs-N2 |
2.202400E-01 |
|
|
